The Effect of Antacids and Multivitamins on Raltegravir
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This study seeks to address the question of whether antacids or multivitamins influence the
pharmacokinetics of raltegravir when co-administered. The aim of this study is to optimise
the dosing of raltegravir when co-administered with antacids or multivitamins.
Phase:
Phase 1
Details
Lead Sponsor:
Helen Reynolds
Treatments:
Aluminum hydroxide, magnesium hydroxide, drug combination Aluminum hydroxide, magnesium hydroxide, simethicone drug combination Antacids Raltegravir Potassium TEMPO